ARCHIVES

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 29 No. 27 | July 4, 2003

Download PDF Visit The Full Archive

Related Articles

Three Congressmen Back Straus Demand For Single Probe

August 28, 1981

In Brief: HHS Names Deputy HCFA Administrator; M.D. Anderson’s Error-Free Record Honored

July 4, 1997

MUSC Hollings Cancer Center awarded NCI designation

February 1, 2021

In Brief: Weiner Elected President-Elect of AACI

February 15, 2013

In Brief: New Spending Plan Funds NIH At FY95 Level; Continuing Resolution Expires Dec. 15

November 24, 1995

Republican Congress To Shift Priorities, But Cancer May Get New Opportunities

November 18, 1994